Results for the substance tezacaftor ivacaftor

This combination of tezacaftor and ivacaftor is used for the treatment of cystic fibrosis in patients with specific genetic mutations of the CFTR gene. Tezacaftor improves the processing and transport of the CFTR protein, while ivacaftor enhances its activity at the cell surface.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important for patients to take the medication with fat-containing food to increase its absorption.

Patients should be monitored for potential side effects, such as headaches, nausea, or respiratory infections. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include headaches, nausea, skin rashes, and upper respiratory tract infections. In rare cases, severe reactions such as elevated liver enzymes or allergic reactions may occur. Patients should be informed of these risks before starting treatment.